Wegovy is a prescription medication designed to assist adults with obesity or overweight conditions in achieving and maintaining weight loss. The active ingredient in Wegovy is semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is a modified version of a naturally occurring hormone in the body that regulates appetite and food intake.
Semaglutide is produced through a fermentation process involving genetically modified bacteria, which allows for the synthesis of the GLP-1 analog. This process results in a stable formulation that can be administered via a subcutaneous injection.
Wegovy is typically prescribed in conjunction with a reduced-calorie diet and increased physical activity. Users may enjoy incorporating it into their weight loss regimen by following their healthcare professional's recommendations, which may include lifestyle changes, dietary modifications, and regular physical activity to achieve optimal results.
Wegovy is taken weekly as an injection under the skin in the upper arms, stomach, thighs, or buttocks. It works by making you feel fuller and less hungry.
Side effects
Common side effects include stomach problems such as nausea, vomiting, diarrhoea, and constipation
You might also notice reactions at the injection site
Some serious side effects include severe allergic reaction, worsening of your diabetic eye disease (diabetic retinopathy), low blood sugar (hypoglycaemia), inflamed pancreas (acute pancreatitis), and possibly bowel obstruction (one of our healthcare professionals will go through the side effects with you during the consultation and you must also read the patient information leaflet thoroughly before taking the medicine)